223 related articles for article (PubMed ID: 22216903)
21. Regulated stability of eukaryotic elongation factor 2 kinase requires intrinsic but not ongoing activity.
Wang X; Xie J; da Mota SR; Moore CE; Proud CG
Biochem J; 2015 Apr; 467(2):321-31. PubMed ID: 25670349
[TBL] [Abstract][Full Text] [Related]
22. Eukaryotic Elongation Factor 2 Kinase a Pharmacological Target to Regulate Protein Translation Dysfunction in Neurological Diseases.
Beretta S; Gritti L; Verpelli C; Sala C
Neuroscience; 2020 Oct; 445():42-49. PubMed ID: 32088293
[TBL] [Abstract][Full Text] [Related]
23. Coordination of changes in expression and phosphorylation of eukaryotic elongation factor 2 (eEF2) and eEF2 kinase in hypertrophied cardiomyocytes.
Kameshima S; Okada M; Ikeda S; Watanabe Y; Yamawaki H
Biochem Biophys Rep; 2016 Sep; 7():218-224. PubMed ID: 28955910
[TBL] [Abstract][Full Text] [Related]
24. [Eukaryotic elongation factor 2 kinase and cancer].
Wang GZ; Qi X; Li J
Yao Xue Xue Bao; 2015 Jul; 50(7):808-13. PubMed ID: 26552140
[TBL] [Abstract][Full Text] [Related]
25. Structural Dynamics of the Activation of Elongation Factor 2 Kinase by Ca
Will N; Lee K; Hajredini F; Giles DH; Abzalimov RR; Clarkson M; Dalby KN; Ghose R
J Mol Biol; 2018 Aug; 430(17):2802-2821. PubMed ID: 29800565
[TBL] [Abstract][Full Text] [Related]
26. Eukaryotic elongation factor 2 kinase confers tolerance to stress conditions in cancer cells.
Zhu H; Yang X; Liu J; Zhou L; Zhang C; Xu L; Qin Q; Zhan L; Lu J; Cheng H; Sun X
Cell Stress Chaperones; 2015 Mar; 20(2):217-20. PubMed ID: 25248493
[TBL] [Abstract][Full Text] [Related]
27. Discovery of new substrates of the elongation factor-2 kinase suggests a broader role in the cellular nutrient response.
Lazarus MB; Levin RS; Shokat KM
Cell Signal; 2017 Jan; 29():78-83. PubMed ID: 27760376
[TBL] [Abstract][Full Text] [Related]
28. Eukaryotic elongation factor 2 (eEF2) kinase/eEF2 plays protective roles against glucose deprivation-induced cell death in H9c2 cardiomyoblasts.
Kameshima S; Okada M; Yamawaki H
Apoptosis; 2019 Apr; 24(3-4):359-368. PubMed ID: 30737648
[TBL] [Abstract][Full Text] [Related]
29. Phosphorylation of elongation factor-2 kinase on serine 499 by cAMP-dependent protein kinase induces Ca2+/calmodulin-independent activity.
Diggle TA; Subkhankulova T; Lilley KS; Shikotra N; Willis AE; Redpath NT
Biochem J; 2001 Feb; 353(Pt 3):621-6. PubMed ID: 11171059
[TBL] [Abstract][Full Text] [Related]
30. Activity of translation regulator eukaryotic elongation factor-2 kinase is increased in Parkinson disease brain and its inhibition reduces alpha synuclein toxicity.
Jan A; Jansonius B; Delaidelli A; Bhanshali F; An YA; Ferreira N; Smits LM; Negri GL; Schwamborn JC; Jensen PH; Mackenzie IR; Taubert S; Sorensen PH
Acta Neuropathol Commun; 2018 Jul; 6(1):54. PubMed ID: 29961428
[TBL] [Abstract][Full Text] [Related]
31. Eukaryotic elongation factor 2 kinase as a drug target in cancer, and in cardiovascular and neurodegenerative diseases.
Liu R; Proud CG
Acta Pharmacol Sin; 2016 Mar; 37(3):285-94. PubMed ID: 26806303
[TBL] [Abstract][Full Text] [Related]
32. Autophosphorylation of Ser-6 via an intermolecular mechanism is important for the rapid reduction of NtCDPK1 kinase activity for substrate RSG.
Ito T; Ishida S; Takahashi Y
PLoS One; 2018; 13(4):e0196357. PubMed ID: 29684069
[TBL] [Abstract][Full Text] [Related]
33. Phosphorylation at Ser²⁶ in the ATP-binding site of Ca²⁺/calmodulin-dependent kinase II as a mechanism for switching off the kinase activity.
Yilmaz M; Gangopadhyay SS; Leavis P; Grabarek Z; Morgan KG
Biosci Rep; 2013 Feb; 33(2):. PubMed ID: 23289753
[TBL] [Abstract][Full Text] [Related]
34. Impact of silencing eEF2K expression on the malignant properties of chordoma.
Aydemir E; Tüysüz EC; Bayrak ÖF; Tecimel D; Hızlı-Deniz AA; Şahin F
Mol Biol Rep; 2023 Apr; 50(4):3011-3022. PubMed ID: 36652154
[TBL] [Abstract][Full Text] [Related]
35. 1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) induces phosphorylation of eukaryotic elongation factor-2 (eEF2): a cautionary note on the anticancer mechanism of an eEF2 kinase inhibitor.
Chen Z; Gopalakrishnan SM; Bui MH; Soni NB; Warrior U; Johnson EF; Donnelly JB; Glaser KB
J Biol Chem; 2011 Dec; 286(51):43951-43958. PubMed ID: 22020937
[TBL] [Abstract][Full Text] [Related]
36. The eEF2 kinase-induced STAT3 inactivation inhibits lung cancer cell proliferation by phosphorylation of PKM2.
Xiao M; Xie J; Wu Y; Wang G; Qi X; Liu Z; Wang Y; Wang X; Hoque A; Oakhill J; Proud CG; Li J
Cell Commun Signal; 2020 Feb; 18(1):25. PubMed ID: 32054489
[TBL] [Abstract][Full Text] [Related]
37. Roles of eukaryotic elongation factor 2 kinase (eEF2K) in neuronal plasticity, cognition, and Alzheimer disease.
Ma T
J Neurochem; 2023 Jul; 166(1):47-57. PubMed ID: 34796967
[TBL] [Abstract][Full Text] [Related]
38. Compartment-specific, differential regulation of eukaryotic elongation factor 2 and its kinase within Aplysia sensory neurons.
Weatherill DB; McCamphill PK; Pethoukov E; Dunn TW; Fan X; Sossin WS
J Neurochem; 2011 Jun; 117(5):841-55. PubMed ID: 21426346
[TBL] [Abstract][Full Text] [Related]
39. Eukaryotic elongation factor-2 kinase (eEF2K) signaling in tumor and microenvironment as a novel molecular target.
Karakas D; Ozpolat B
J Mol Med (Berl); 2020 Jun; 98(6):775-787. PubMed ID: 32377852
[TBL] [Abstract][Full Text] [Related]
40. Lopinavir impairs protein synthesis and induces eEF2 phosphorylation via the activation of AMP-activated protein kinase.
Hong-Brown LQ; Brown CR; Huber DS; Lang CH
J Cell Biochem; 2008 Oct; 105(3):814-23. PubMed ID: 18712774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
